glp 1 eye GLP-1 Drugs and Ocular Disease: Between Neuroprotection and Risk GLP-1 Medicines (such as Ozempic)

Results The interaction test yielded no significant differences between the effects of the four daily oral maintenance dosages of L-carnitine (i.e., 2 g, 3 g, 4 g, and 6 g) on all-cause mortality (risk ratio [RR] = 0.77, 95% CI [0.57-1.03], P = 0.08) with a statistically insignificant trend favoring the 3 g dose (RR = 0.48) over the lower 2 g dose (RR = 0.62), which was favored over the higher 4 g and 6 g doses (RR = 0.78, 0.78)

Gioilli BD, Kidane TZ, Fieten H, et al

Brain Res (1988) 441(1-2):4037

Johnson BV et al

Overall, however, chocolate doesnt appear to be the miracle drug its been touted as for the last millennium and a half

Without that noise, healthier choices felt easier